title: Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994.
abstract: OBJECTIVE
  To estimate the rate of progression of plexiform neurofibroma after surgery and to identify prognostic factors that predict progression.
  
  
  METHODS
  A retrospective review of the inpatient and outpatient records of 121 patients, who had 302 procedures on 168 tumors over a 20-year period at a single large pediatric referral center. Data on age, location, indication for surgery, and extent of resection was analyzed for prognostic significance.
  
  
  RESULTS
  The overall freedom from progression was 54%. Children < 10 years old had a shorter interval of tumor control than older children (p = 0.0004). Tumors of the head/neck/face fared worse than tumors of the extremities (p = 0.0003). Less extensive resection predicted shorter interval to progression (p < 0.0001). Indication for surgery was not of prognostic importance. In multivariable analysis older age and location in the extremities were predictors of a better outcome.
  
  
  CONCLUSIONS
  Tumor progression is a serious problem for children with plexiform neurofibroma. Younger children, children with tumors of the head/neck/face, and tumors that cannot be nearly completely removed are at particular risk. These data may be useful in helping clinicians decide which patients and which tumors are most likely to benefit from surgical intervention.
authors.affiliation: Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania 19104, USA.
authors.forename: M N
authors.initials: MN
authors.lastname: Needle
authors.forename: A
authors.initials: A
authors.lastname: Cnaan
authors.forename: J
authors.initials: J
authors.lastname: Dattilo
authors.forename: J
authors.initials: J
authors.lastname: Chatten
authors.forename: P C
authors.initials: PC
authors.lastname: Phillips
authors.forename: S
authors.initials: S
authors.lastname: Shochat
authors.forename: L N
authors.initials: LN
authors.lastname: Sutton
authors.forename: S N
authors.initials: SN
authors.lastname: Vaughan
authors.forename: E H
authors.initials: EH
authors.lastname: Zackai
authors.forename: H
authors.initials: H
authors.lastname: Zhao
authors.forename: P T
authors.initials: PT
authors.lastname: Molloy
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006258:Head and Neck Neoplasms / Q000453:epidemiology / Q000601:surgery*; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008137:Longitudinal Studies; D008297:Male; D009369:Neoplasms / Q000453:epidemiology / Q000601:surgery*; D018318:Neurofibroma, Plexiform / Q000453:epidemiology / Q000601:surgery*; D009456:Neurofibromatosis 1 / Q000453:epidemiology / Q000601:surgery*; D010414:Pennsylvania; D010524:Peripheral Nervous System Neoplasms / Q000453:epidemiology / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D013125:Spinal Neoplasms / Q000453:epidemiology / Q000601:surgery*; D013997:Time Factors